BIM
SRNE

Bogle Investment Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bogle Investment Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-155,805
Closed -$802K – 375
2018
Q1 		$802K Buy
+155,805
New +$1.11M 0.06% 245

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
IP
Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bogle Investment Management's SRNE Position: Q2 2018 in Review

Bogle Investment Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2018, closing a stake of 155,805 shares — an estimated $802K sold.

Bogle Investment Management first reported a position in SRNE in Q1 2018 and held it in 1 quarter. The position peaked at $802K in Q1 2018. 94 funds tracked by Wall St. Rank hold SRNE as of Q2 2018.

  • Bogle Investment Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bogle Investment Management sold 155,805 Sorrento Therapeutics, Inc. shares in Q2 2018, an estimated $802K.
  • Bogle Investment Management first reported a position in Sorrento Therapeutics, Inc. in Q1 2018 and held it in 1 quarter.
  • Bogle Investment Management's Sorrento Therapeutics, Inc. position peaked at $802K in Q1 2018.
  • 94 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2018.

Based on Bogle Investment Management's 13F filing for Q2 2018, filed 13 Aug 2018.